Who
Stuart Rich
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Tenax Therapeutics.
In numbers
- Trades disclosed
- 22
- Buys
- 5
- Sells
- 0
- Bought
- $96K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Jan 2021
- Last trade
- 9 Jan 2026
- Last filed
- 13 Jan 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jan 2026filed 13 Jan 2026 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 9 Dec 2025filed 10 Dec 2025 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Bought | $26K2,500 at $10.22 | filing |
| 8 Dec 2025filed 10 Dec 2025 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Bought | $25K2,500 at $10.10 | filing |
| 4 Dec 2025filed 5 Dec 2025 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Bought | $23K2,500 at $9.20 | filing |
| 3 Dec 2025filed 5 Dec 2025 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Bought | $14K1,500 at $9.08 | filing |
| 2 Dec 2025filed 5 Dec 2025 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Bought | $9,0101,000 at $9.01 | filing |
| 16 May 2025filed 20 May 2025 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —625,000 at $0.00 | filing |
| 10 Dec 2024filed 12 Dec 2024 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 17 May 2024filed 21 May 2024 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —119 at $0.00 | filing |
| 21 Sep 2022filed 23 Sep 2022 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Code G | —1,909,585 at $0.00 | filing |
| 21 Sep 2022filed 23 Sep 2022 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Code G | —1,909,585 at $0.00 | filing |
| 9 Jun 2022filed 10 Jun 2022 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 29 Nov 2021filed 6 Dec 2021 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Code G | —1,909,585 at $0.00 | filing |
| 29 Nov 2021filed 6 Dec 2021 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Code G | —1,909,585 at $0.00 | filing |
| 12 Oct 2021filed 6 Dec 2021 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Code G | —1,909,585 at $0.00 | filing |
| 12 Oct 2021filed 6 Dec 2021 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Code G | —1,909,585 at $0.00 | filing |
| 11 Jun 2021filed 15 Jun 2021 | TENX Tenax TherapeuticsBiotechnology | SEC FORM 4 Code M | —3,581,000 | filing |
| 11 Jun 2021filed 15 Jun 2021 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,581 | filing |
| 15 Jan 2021filed 27 Jan 2021 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
News
Tenax Therapeutics (NASDAQ:TENX) Stock: Insider Adar1 Capital Management, Llc Acquires 336,528 SharesTENX · dailypolitical.com · 21 Oct 2026
0 headlines in the last 90 days name Stuart Rich; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.